Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 5/20 | 0.46 |
| ▸ | S1PR1 | P21453 | 5/20 | 0.46 |
| ▸ | S1PR3 | Q99500 | 5/20 | 0.46 |
| ▸ | S1PR4 | O95977 | 4/20 | 0.46 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | LAP3 | P28838 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | GRIK1 | P39086 | 2/20 | 0.42 |
| ▸ | GRIK2 | Q13002 | 2/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.41 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.41 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7103472 | 0.86 | ALDH1A1 (0.47) | S1PR2S1PR1S1PR3S1PR4ZDHHC7 | |
| SCHEMBL27617597 | 0.83 | MAPT (0.46) | S1PR2S1PR1S1PR3S1PR4ZDHHC7 | |
| SCHEMBL15954723 | 0.82 | S1PR2 (0.45) | S1PR2S1PR1S1PR3S1PR4ZDHHC7 | |
| SCHEMBL27879714 | 0.82 | S1PR2 (0.45) | S1PR2S1PR1S1PR3S1PR4ZDHHC7 | |
| SCHEMBL1736123 | 0.82 | S1PR2 (0.45) | S1PR2S1PR1S1PR3S1PR4ZDHHC7 | |
| SCHEMBL9845854 | 0.80 | TSHR (0.54) | S1PR2S1PR1S1PR3S1PR4ZDHHC7 | |
| SCHEMBL27860089 | 0.80 | S1PR2 (0.40) | S1PR2S1PR1S1PR3S1PR4ZDHHC7 | |
| SCHEMBL27795491 | 0.80 | CA1 (0.44) | S1PR2S1PR1S1PR3S1PR4ALDH1A1 | |
| SCHEMBL11332448 | 0.79 | MAPT (0.58) | ALDH1A1 | |
| SCHEMBL22230486 | 0.79 | S1PR2 (0.42) | S1PR2S1PR1S1PR3S1PR4ZDHHC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100041622-A1 | Compositions containing aminoalkanes and aminoalkane derivatives | VIRUN, INC. | 2010-02-18 | — | — | US | disclosed |
| WO-2010019255-A1 | COMPOSITIONS CONTAINING AMINOALKANES AND AMINOALKANE DERIVATIVES | VIRUN, INC. (US) | 2010-02-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100041622-A1 | Compositions containing aminoalkanes and aminoalkane derivatives | TAAR5, PDE3A, PDE2A | S1PR2 681/4885S1PR1 688/4885S1PR3 395/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.